Effects of secondary hyperparathyroidism treatment on hemoglobin levels and erythropoietin doses in hemodialysis patients
Crossref DOI link: https://doi.org/10.29328/journal.jcn.1001081
Published Online: 2021-10-15
Published Print: 2021-10-15
Update policy: https://doi.org/10.29328/crossmark-policy
Carlo, Massimetti
Antonio, Bellasi
Sandro, Feriozzi
Version of Record valid from 2013-11-25
Accepted Manuscript valid from 2016-04-18
